{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T11:13:00Z","timestamp":1698145980374},"reference-count":21,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,6,3]],"date-time":"2005-06-03T00:00:00Z","timestamp":1117756800000},"content-version":"vor","delay-in-days":4171,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genetic Epidemiology"],"published-print":{"date-parts":[[1994,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human acetylation phenotypes were determined with caffeine (137X) as the test substance, improved by measuring urinary caffeine metabolites with a previously described HPLC method. Caffeine, 5\u2010acetylamino\u20106\u2010formylamino\u20103\u2010methyluracil (AFMU), 1\u2010methylxanthine (1X), 1\u2010methyluric acid (IU), 1,7\u2010dimethylxanthine (17X), and 1,7\u2010dimethyluric acid (17U) were quantified. This study tested the hypothesis, suggested by previous studies, that the acetylation polymorphism is strongly influenced by a major gene. Phenotypes were assessed by using four urinary caffeine metabolite ratios: AFMU\/1X, AFMU\/[1X + 1U + 17U], AFMU\/[AFMU + 1X + 1U], and AFMU\/[1X + 1U + 17X + 17U] in a population included 281 nuclear family members who were healthy volunteer subjects. Each urinary ratio revealed strong familial aggregation with correlations between parents and offspring varying from 0.340 to 0.486 as a function of the ratio considered, and between sibs from 0.410 to 0.512 whereas correlations among spouses were not significant, excluding an effect of environmental factors. Segregation analyses were conducted upon these four ratios testing a series of specific models of inheritance and gave evidence for single locus control of N\u2010acetyltransferase (NAT) activity, with Mendelian codominant transmission using the AFMU\/1X, AFMU\/[1X + 1U + 17U], and AFMU\/[1X + 1U + 17X + 17U] ratios. The slow allelic frequencies were 0.739, 0.753, and 0.724, respectively, and the phenotypic concordance was 90 to 92% with the AFMU\/1X ratio. The familial aggregation observed in using the AFMU\/[AFMU + 1X + 1U] ratio was consistent with a recessive transmission for the allele controlling the homozygous slow phenotype. This last ratio is not convenient to differentiate rapid heterozygous and homozygous phenotype. Considering the number of misclassified subjects, this study would be completed by genotyping the same families as demonstrated by some authors who predicted 97.5% of acetylation phenotype when using PCR\u2010based DNA amplification test. \u00a9 1994 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/gepi.1370110203","type":"journal-article","created":{"date-parts":[[2005,6,11]],"date-time":"2005-06-11T21:57:51Z","timestamp":1118527071000},"page":"115-129","source":"Crossref","is-referenced-by-count":2,"title":["Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes"],"prefix":"10.1002","volume":"11","author":[{"given":"Monique","family":"Vincent\u2010Viry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelia Braz Vieira","family":"da Silva Pontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Gueguen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie\u2010Madeleine","family":"Galteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Siest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,6,3]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.124"},{"key":"e_1_2_1_3_1","first-page":"59","article-title":"Acetylation phenotype and biological variation in a French Caucasian population","volume":"31","author":"da Silva Pontes Z","year":"1993","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199206000-00003"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1989.tb03321.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/clinchem\/35.5.848","article-title":"A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites","volume":"35","author":"El\u2010Yazigi A","year":"1989","journal-title":"Clin Chem"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02220616"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199302000-00005"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.45"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02372.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114527"},{"key":"e_1_2_1_12_1","first-page":"184","article-title":"Monomorphic and polymorphic human arylamine N\u2010acetyltransferases: A comparison of liver isoenzymes and expressed products of two cloned genes","volume":"39","author":"Grant DM","year":"1991","journal-title":"Mol Pharmacol"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498259209051861"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.130"},{"key":"e_1_2_1_15_1","volume-title":"PAP: Pedigree Analysis Package","author":"Hasstedt SJ","year":"1989"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558136"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.59"},{"key":"e_1_2_1_18_1","first-page":"95","volume-title":"Pharmacogenetics of Drug Metabolism","author":"Evans DA Price","year":"1992"},{"key":"e_1_2_1_19_1","first-page":"394","article-title":"Human acetylation polymorphism","volume":"63","author":"Evans DA Price","year":"1984","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_20_1","volume-title":"Interpretation of Clinical Laboratory Tests","author":"Siest G","year":"1985"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.189"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1991.82"}],"container-title":["Genetic Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fgepi.1370110203","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/gepi.1370110203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T01:25:46Z","timestamp":1698110746000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/gepi.1370110203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["10.1002\/gepi.1370110203"],"URL":"https:\/\/doi.org\/10.1002\/gepi.1370110203","archive":["Portico"],"relation":{},"ISSN":["0741-0395","1098-2272"],"issn-type":[{"value":"0741-0395","type":"print"},{"value":"1098-2272","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}